Sionna Chief Legal Officer Cashed Out Her Shares. Her Options Are Another Story [Yahoo! Finance]
Sionna Therapeutics, Inc. (SION)
Company Research
Source: Yahoo! Finance
disposed of 10,250 shares of common stock via a derivative-based sale, according to a SEC Form 4 filing Transaction summary Metric Value Shares sold (direct) Transaction value ~$347,000 Post-transaction shares (direct) Post-transaction value (direct ownership) ~$0 Transaction value based on SEC Form 4 weighted average purchase price ($33.86). Key questions What was the structure and context of this transaction? The transaction involved exercising 10,250 options for common stock, which were immediately sold in the open market. How does this sale impact Fitzpatrick's ownership in Sionna Therapeutics? This sale reduced her direct holdings of common stock to zero. What proportion of Fitzpatrick's available common shares did this sale represent? The disposal accounted for 100.00% of her direct common stock holdings at the time of the transaction, reflecting a complete turnover of directly owned shares. How does the transaction fit within recent capacity
Show less
Read more
Impact Snapshot
Event Time:
SION
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SION alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SION alerts
High impacting Sionna Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SION
News
- Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation SymposiumGlobeNewswire
- Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet? [Yahoo! Finance]Yahoo! Finance
- Hot Picks: Biotech picks target cystic fibrosis trials and rare-disease drugs [BNN Bloomberg (Canada)]BNN Bloomberg
- This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares [Yahoo! Finance]Yahoo! Finance
- Sionna Therapeutics (SION) had its "buy" rating reaffirmed by UBS Group AG.MarketBeat
SION
Earnings
- 11/5/25 - Beat
SION
Sec Filings
- 4/16/26 - Form 4
- 4/16/26 - Form 4
- 3/6/26 - Form 4
- SION's page on the SEC website